Low-density Lipoprotein Cholesterol - ASCVD & Lipidology Knowledge Hub

This site is only for use by healthcare professionals. By continuing to view this site you are confirming that you are a healthcare professional.

Confirm
  • Share

  • Stay up to date
  • Home
  • Topics
    • Acute Coronary Syndrome
    • Alirocumab
    • Apolipoprotein B
    • ASCVD
    • Aspirin
    • Atherosclerosis
    • Cholesterol
    • Congresses
    • Coronary artery disease
    • CVD
    • CVD Risk Factor
    • Dyslipidemia
    • Evolocumab
    • Ezetimibe
    • Familial hypercholesterolemia
    • Guidelines
    • High-density lipoprotein
    • Hypercholesterolemia
    • Inclisiran
    • Influenza
    • Lipids
    • Lipoprotein (a)
    • Low-density lipoprotein
    • Low-density Lipoprotein Cholesterol
    • Myocardial Infarction
    • PCSK9
    • Pediatric Population
    • Short interfering RNA (siRNA)
    • Statin
    • Trials
    • Triglycerides
    • Vaccination
  • Videos
  • Infographics
  • Articles
  • Case Studies
  • Webinar
  • Faculty
  • Stay up to date

Low-density Lipoprotein Cholesterol

Articles

  • Articles

    Early initiation of PCSK9 inhibition in myocardial infarction could be EPIC for patient care

    View
  • Articles

    Knowledge of HbA1c and LDL-C treatment goals, subjective level of disease-related information and information needs in patients with atherosclerotic cardiovascular disease

    View

How would you rate this content?

  • © John Wiley & Sons, Ltd. All rights reserved.
  • Privacy Policy
  • Terms of use
  • Stay up to date
  • Cookie Preferences
  • This Knowledge Hub is supported by Novartis.
Clinical Cardiology